There have been multiple accounts created with the sole purpose of posting advertisement posts or replies containing unsolicited advertising.

Accounts which solely post advertisements, or persistently post them may be terminated.

Kolanaki ,
@Kolanaki@yiffit.net avatar

No thanks.

If there’s no risk of cancer, what’s the point of smoking tobacco? 🤷🏻‍♂️

ExLisper ,

Hey, it’s already before 2030. Where’s my vaccine?

Tranquilizer ,

Selling the cause as the cure. Brilliant marketing. The useless eaters are too gullible not to take it I’m afraid.

greybeard ,

Am I misunderstanding you or are you saying that vaccines are causing cancer? Because if that is what you are saying, what are you smoking?

OKRainbowKid , (edited )

That’s exactly what they’re saying, while ironically calling reasonable people gullible and considering themself enlightened.

Tranquilizer ,

Y’all should look into eugenics as an origin for modern vaccines. Or how autism is to an umbrella term and euphemism for vaccine damage. If you want something relevant from 2021: sudden adult death syndrome.

ExLisper ,

Isn’t the origin of modern vaccines the same as origin of old vaccines? When did vaccines became ‘modern’? When they started placing 5G chips in them or before that?

Tranquilizer ,

Yes, when the Borg came to earth and the people chose to assimilate. Resistance would have been futile.

Captainvaqina ,

Holy shit you’re reeeeeaaaaallllly dumb.

TheGrandNagus ,

People falling for facebook pseudoscience calling other people gullible will never not be hilarious to me.

silverbax ,

We really need some vetting on the ‘sources’ posted here. Lemmy is voting up stories based on headlines from BS links.

pleb_maximus ,

The bots google translate link is borked, but ZDF isn’t exactly a BS source.

sndrtj ,

ZDF is a major broadcaster in Germany.

silverbax ,

Then they should do a better job vetting their stories, this is a medical bunk press release.

BedSharkPal ,

But like… Which cancer?

tsonfeir ,
@tsonfeir@lemm.ee avatar

Right? Not all cancer is the same on a cellular level and to think there would be a vaccine against “cellular mutation” as a broad topic would be asinine. Especially since a lot of those mutations are from environmental exposure.

I’m certainly not one to dismiss scientific progress, but call me skeptical about the 1,000th cure/treatment/vaccine for “cancer” announcement this year.

crashfrog ,

But cancers aren’t generally random mutations; they’re specific mutations to specific genes (oncogenes) that tend to be associated with cell replication and planned cell death.

So it actually does make sense that you can target cancer mutations, since you’re looking at a fairly small set of mutations (about 300, I think.) In any case, the body destroying its own pre-cancerous cells is an important mechanism for day-to-day cancer prevention that’s already working in people, so it makes sense to try to strengthen and broaden the response.

SCB ,

Not all cancer is the same on a cellular level

I’m certainly not one to dismiss scientific progress, but call me skeptical about the 1,000th cure/treatment/vaccine for “cancer” announcement this year.

One imagines there are many cure/treatment/vaccines because there are many different cancers

Maalus ,

Yet they all scream “we have found a cure for cancer!” As if they have found one for all of them.

SCB ,

They have literally found a cure for cancer. This is one application.

tsonfeir ,
@tsonfeir@lemm.ee avatar

You missed the point of the comment.

anteaters ,

If only there was an article linked that contains quotations of Sahin giving examples. Oh if only someone even copy-pasted that as a comment into this thread.

Daxtron2 ,

Can you translate it into a 3 second gif for me? I can’t read

DirigibleProtein ,

Alternative to chemotherapy

:

BioNTech plans cancer vaccines before 2030

26.11.2023 | 12:01

|

Can we hope for an alternative to chemotherapy in the fight against cancer soon? The head of the vaccine manufacturer BioNTech expects a vaccine before 2030.

BioNTech boss Ugur Sahin says: “We want to develop cancer immunotherapies so that the body’s own defense system can fight cancer.” (Archive image)

Source: dpa

In the fight against cancer, there could soon be hope for those affected. The vaccine manufacturer BioNTech assumes that the first tailor-made mRNA-based vaccines against cancer could be approved within the next few years. BioNTech boss Ugur Sahin said [to] “Bild am Sonntag”:

We expect that our first mRNA-based cancer vaccines can be approved before 2030.

Ugur Sahin, BioNTech

In addition, it is planned to have “study data available for various other therapeutic approaches in the years 2025 to 2029.” If they are positive, approval is possible according to the assessment of the BioNTech boss.

Through mRNA, the immune system should learn to recognize “high-personal” cancer cells and then fight them specifically. What is the current state of research?

Cancer therapy: BioNTech relies on the body’s own defense system

Specifically, BioNTech’s approach provides for cancer immunotherapy in which the body’s own defense system can fight cancer.

“We believe that this is one of the central elements to control cancer in the long term or ideally to be able to cure it.” In addition, there are already immunotherapies against various types of cancer in clinical development, explains Sahin and further explains:

For example, in breast cancer in the metastatic stage, in colon cancer after surgery, i.e. in the adjuvant stage, as well as in pancreatic cancer and lung cancer.

Prostate cancer is well curable if it is detected in time. This is possible with the so-called PSA value, which in Germany, however, is not paid by the health insurance companies.

BioNTech wants to provide individualized vaccine

The aim of BioNTech is to set up a company in such a way that it can technologically map all the necessary steps of a therapy within a short time. The BioNTech founder explains:

The goal is: We receive a blood and tumor sample of the patient and after four weeks we provide the individualized vaccine.

This should ideally be possible for tens of thousands of patients a year.

BioNTech had each made billions in profits in the past two years from proceeds from the vaccine against the coronavirus and now wants to promote the development of therapies, for example against cancer.

Source: ZDF

BlackSkinnedJew ,

Let me guess, it will be expensive…

Fades ,

They ain’t Salk, you better believe it’ll be expensive

BlackSkinnedJew ,

Then people didn’t believe about depopulation conspiracy theories, making a cancer vaccine what will be affordable only for a small % of the population it’s a fucking depopulation techinique, you don’t need to be a genius to realize it.

konalt ,
@konalt@lemmy.world avatar

Link is dead.

AlmightySnoo ,
@AlmightySnoo@lemmy.world avatar

Looks like the bot’s Google Translate link doesn’t work. If you have Firefox, you can open the original link in German (zdf.de/…/biontech-krebs-forschung-impfstoff-100.h… ) and then use the offline translation that’s available in recent Firefox versions, it’s fast and pretty accurate.

I’m not sure what’s new though, as they’ve already stated that goal last year: theguardian.com/…/vaccines-to-treat-cancer-possib…

  • All
  • Subscribed
  • Moderated
  • Favorites
  • •
  • [email protected]
  • random
  • lifeLocal
  • goranko
  • All magazines
    •